kumar
☆    

2009-05-29 10:14
(6240 d 01:57 ago)

Posting: # 3786
Views: 2,376
 

 BE for Metformin 1000 mg ER Tabs [Design Issues]

Post reply
I have to design the BE Studies for single dose Metformin 1000 mg Extended Release Tablets. Its in-vitro dissolution profile is: After 1 hour = 20 - 40%; after 2 hours = 35 - 55%; after 6 hours = 65 - 85% and after 10 hours NLT 85%. Can someone suggest me, at what time intervals should the plasma samples from volunteers be taken to determine drug concentration to co-relate with the in-vitro data as well as to determine AUC effectively.

Thank you and regards,

Kumar
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
202 visitors (0 registered, 202 guests [including 20 identified bots]).
Forum time: 12:12 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5